UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000061088 |
|---|---|
| Receipt number | R000069892 |
| Scientific Title | Empirical Study on the Impact of Far-Infrared Blood Circulation-Promoting Garments on Productivity in Medical Institutions |
| Date of disclosure of the study information | 2026/03/30 |
| Last modified on | 2026/03/27 22:46:08 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Empirical Study on the Impact of Far-Infrared Blood Circulation-Promoting Garments on Productivity in Medical Institutions
Acronym
Empirical Study on the Impact of Far-Infrared Blood Circulation-Promoting Garments on Productivity in Medical Institutions
Scientific Title
Empirical Study on the Impact of Far-Infrared Blood Circulation-Promoting Garments on Productivity in Medical Institutions
Scientific Title:Acronym
Empirical Study on the Impact of Far-Infrared Blood Circulation-Promoting Garments on Productivity in Medical Institutions
Region
| Japan |
Condition
Condition
Healthy subjects
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the impact of wearing far-infrared blood circulation-promoting garments on health status and labor productivity
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Labor productivity (Amount of loss)
Key secondary outcomes
Somatic Symptom Scale, Sleep quality, Depression risk, Work engagement
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Other |
Interventions/Control_1
Group A (Lead-in Intervention Group): Intervention (wearing the test product) will be conducted for 6 months immediately following the pre-study survey, followed by a 6-month optional wearing period (observation period).
Interventions/Control_2
Group B (Partial Non-Intervention Group): The one-month period following the pre-study survey will serve as a non-intervention observation period. Intervention (wearing the test product) will be conducted for 6 months from the 1st to the 7th month, followed by a 6-month optional wearing period (observation period) until the 13th month.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1)Persons engaged in work at medical institutions
2)Persons who have received a sufficient explanation of the purpose and content of the study and have consented to participate of their own free will
Key exclusion criteria
1)Persons at risk of showing allergic symptoms due to the materials of the research products
2)Persons who cannot follow the instructions of the principal investigator, or those whom the principal investigator deems inappropriate
3)Others whom the principal investigator deems ineligible as study subjects
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Takao |
| Middle name | |
| Last name | Muto |
Organization
MTG Co., Ltd.
Division name
VITALTECH Business Support Division, Academic Planning Department
Zip code
453-0041
Address
MTG Dai-2 HIKARI Bldg., 4-13 Honjindori, Nakamura-ku, Nagoya-shi, Aichi 453-0041, Japan
TEL
052-481-5001
takao.muto@mtg.gr.jp
Public contact
Name of contact person
| 1st name | Kenta |
| Middle name | |
| Last name | Ochiai |
Organization
Macromill, Inc.
Division name
Clinical Trial Department, Life Science Division
Zip code
108-0075
Address
Shinagawa East One Tower 11F, 2-16-1 Konan, Minato-ku, Tokyo, Japan
TEL
03-6716-0700
Homepage URL
umin@macromill.com
Sponsor or person
Institute
Macromill, Inc.
Institute
Department
Personal name
Funding Source
Organization
MTG Co., Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Saitama Prefectural University
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethical Committee of Kobuna Orthopedics
Address
311-2 Joto-machi, Maebashi-shi, Gumma
Tel
027-212-5608
sagawa@mc-connect.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 03 | Month | 30 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 01 | Month | 29 | Day |
Date of IRB
| 2026 | Year | 01 | Month | 29 | Day |
Anticipated trial start date
| 2026 | Year | 03 | Month | 30 | Day |
Last follow-up date
| 2027 | Year | 05 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 03 | Month | 27 | Day |
Last modified on
| 2026 | Year | 03 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069892
